Regenerative

Where this fits in the regenerative sequence: OsseoSeal Mineralized Cortico-Cancellous Bone is typically placed during the grafting phase following extraction site debridement or defect preparation, when clinicians need a particulate graft material that balances structural support with biological integration.

Why clinicians select cortico-cancellous bone blends

• Chosen for its 50/50 cortical and cancellous composition, providing a balance of space maintenance and handling characteristics.
• Commonly selected for small-volume grafting procedures where precise placement and controlled delivery are important.
• Preferred when syringe delivery supports efficient chairside application with minimal graft waste.

In-use behavior

In use, the mineralized particulate displays stable handling and controlled flow, allowing clinicians to place graft material directly into sockets or contained defects while maintaining graft position prior to membrane placement or closure.

Clinical context

This graft is commonly incorporated into regenerative workflows such as socket preservation, minor ridge defects, and localized GBR, where clinicians want predictable handling in a compact volume format.

Technical snapshot

• Mineralized cortico-cancellous bone graft
• 50% cortical / 50% cancellous composition
• Preloaded syringe for controlled delivery
• Volume: 0.3 cc
• Designed for small regenerative procedures

ApexDent note: OsseoSeal Mineralized Cortico-Cancellous Bone (0.3cc) is selected when clinicians want a balanced particulate graft delivered with precision for small, well-defined regenerative indications.

Where this fits in the regenerative sequence: OsseoSeal Mineralized Cortico-Cancellous Bone (0.5cc) is typically placed during the grafting phase following extraction site debridement or defect preparation, when clinicians require a slightly larger graft volume while maintaining controlled placement.

Why clinicians select cortico-cancellous bone blends

• Chosen for its 50/50 cortical and cancellous composition, offering a balance of space maintenance and handling characteristics.
• Commonly selected for moderate-volume grafting procedures where precise delivery remains important but additional material is required.
• Preferred when syringe delivery supports efficient placement with reduced graft handling and waste.

In-use behavior

In use, the mineralized particulate exhibits controlled flow and stable handling, allowing clinicians to place graft material directly into sockets or contained defects while maintaining graft position prior to membrane placement or closure.

Clinical context

This graft is commonly incorporated into regenerative workflows such as socket preservation, localized ridge augmentation, and contained GBR defects, where a slightly larger graft volume is beneficial without moving to bulk packaging.

Technical snapshot

• Mineralized cortico-cancellous bone graft
• 50% cortical / 50% cancellous composition
• Preloaded syringe for controlled delivery
• Volume: 0.5 cc
• Designed for small-to-moderate regenerative procedures

ApexDent note: OsseoSeal Mineralized Cortico-Cancellous Bone (0.5cc) is selected when clinicians want balanced particulate handling with additional volume for contained regenerative indications.

Where this fits in the regenerative sequence: OsseoSeal Mineralized Cortico-Cancellous Bone (1cc) is placed during the grafting phase following extraction site debridement or defect preparation, when clinicians require additional graft volume or prefer to divide material across multiple sites.

Why clinicians select split-volume cortico-cancellous grafts

• Chosen for its 50/50 cortical and cancellous composition, balancing structural stability with manageable handling characteristics.
• Commonly selected when multiple sockets or localized defects are treated in a single appointment.
• Preferred when separate syringes support controlled use and reduced material waste across procedures.

In-use behavior

In use, the mineralized particulate demonstrates stable handling with controlled delivery, allowing clinicians to place graft material directly into contained sites while maintaining graft position prior to membrane placement or closure.

Clinical context

This configuration is commonly incorporated into regenerative workflows such as multi-socket preservation, staged grafting procedures, and localized ridge augmentation, where flexibility in material use is preferred over single-syringe volume.

Technical snapshot

• Mineralized cortico-cancellous bone graft
• 50% cortical / 50% cancellous composition
• Preloaded syringes for controlled delivery
• Total volume: 1.0 cc
• Packaging: 2 × 0.5 cc syringes
• Designed for flexible, multi-site regenerative procedures

ApexDent note: OsseoSeal Mineralized Cortico-Cancellous Bone (1cc, 2 × 0.5cc) is selected when clinicians want balanced graft handling with the flexibility to treat multiple sites while maintaining controlled placement.

Where this fits in the regenerative sequence: The Cortical/Cancellous Allograft Powder (5cc) is used during the grafting phase following site preparation, when clinicians require a particulate bone graft for socket preservation, ridge augmentation, or contained regenerative defects.

Why clinicians select cortical/cancellous allograft powders

• Chosen for its 50/50 cortical and cancellous composition, balancing space maintenance with manageable handling characteristics.
• Commonly selected when particle size range of 250–1000 µm supports adaptability across a variety of contained defects.
• Preferred when bulk packaging allows flexibility across multiple procedures or larger grafting sites.

In-use behavior

In use, the particulate allograft demonstrates stable handling and adaptable packing behavior, allowing clinicians to hydrate, blend, and place the material according to site morphology prior to membrane placement or closure.

Clinical context

This graft is commonly incorporated into regenerative workflows such as socket preservation, localized ridge augmentation, and guided bone regeneration, where clinicians want a versatile particulate graft supplied in a bulk, multi-pack format.

Technical snapshot

• Mineralized cortical/cancellous allograft powder
• 50% cortical / 50% cancellous composition
• Particle size: 250–1000 µm
• Total volume: 5.0 cc
• Packaging: 2 × 2.5 cc packs
• Designed for moderate to larger regenerative procedures

ApexDent note: This Cortical/Cancellous Allograft Powder (5cc) is selected when clinicians want a balanced, versatile particulate graft supplied in a format that supports multiple or larger regenerative indications.

Where this fits in the regenerative sequence: The Cortical/Cancellous Allograft (2.5cc) is used during the grafting phase following site debridement or defect preparation, when clinicians require a particulate bone graft for small or localized regenerative indications.

Why clinicians select cortical/cancellous allograft

• Chosen for its 50/50 cortical and cancellous composition, providing a balance of structural stability and adaptable handling.
• Commonly selected when a 250–1000 µm particle range supports packing into contained defects or extraction sockets.
• Preferred when a single-site volume is sufficient and bulk packaging is unnecessary.

In-use behavior

In use, the particulate allograft demonstrates stable handling and controlled packing behavior, allowing clinicians to hydrate and place the material according to site morphology prior to membrane placement or closure.

Clinical context

This graft is commonly incorporated into regenerative workflows such as single-socket preservation, localized ridge defects, and small GBR procedures, where controlled volume and predictable handling are preferred.

Technical snapshot

• Mineralized cortical/cancellous allograft
• 50% cortical / 50% cancellous composition
• Particle size: 250–1000 µm
• Volume: 2.5 cc
• Designed for localized regenerative procedures

ApexDent note: The Cortical/Cancellous Allograft (2.5cc) is chosen when clinicians want a balanced particulate graft in a compact volume for focused regenerative applications.

Where this fits in the regenerative sequence: The Cortical/Cancellous Allograft (1cc Jar) is used during the grafting phase following site debridement or defect preparation, when clinicians require a small-volume particulate bone graft with flexible handling.

Why clinicians select jar-based cortical/cancellous allografts

• Chosen for its 50/50 cortical and cancellous composition, balancing space maintenance with adaptable packing behavior.
• Commonly selected when a 250–1000 µm particle size range supports controlled placement into contained defects or extraction sockets.
• Preferred when a jar format allows clinicians to hydrate, blend, or portion material according to site-specific needs.

In-use behavior

In use, the particulate allograft demonstrates stable handling and adaptable packing characteristics, allowing clinicians to transfer, hydrate, and place the material incrementally prior to membrane placement or site closure.

Clinical context

This graft is commonly incorporated into regenerative workflows such as single-socket preservation, minor ridge defects, and small GBR procedures, where precise volume control and material flexibility are preferred.

Technical snapshot

• Mineralized cortical/cancellous allograft
• 50% cortical / 50% cancellous composition
• Particle size: 250–1000 µm
• Packaging: 1 cc jar
• Designed for localized regenerative procedures

ApexDent note: The Cortical/Cancellous Allograft (1cc Jar) is chosen when clinicians want a balanced particulate graft in a flexible, small-volume format for focused regenerative applications.